Αποτελέσματα Αναζήτησης
Learn about the benefits, risks, and uncertainties of prostate cancer screening and how to make an informed decision with your health care provider. The ACS recommends screening for men at different ages and risk levels based on the PSA blood test and the digital rectal exam.
8 Μαΐ 2018 · The US Preventive Services Task Force (USPSTF) provides guidance on the benefits and harms of prostate-specific antigen (PSA)-based screening for prostate cancer. The recommendation depends on age, race, family history, and patient preferences, and is updated regularly.
Learn about the PSA test, a blood test that measures the level of prostate-specific antigen in the blood. Find out the benefits and harms of PSA screening, the factors that affect PSA levels, and the alternatives to PSA testing.
Current guidelines on PSA testing. Guidelines vary in their recommendations on PSA testing (see table 1).
This guideline provides recommendations for prostate cancer screening using PSA and other tools based on age, risk and shared decision-making. It reviews the evidence for the benefits and harms of screening and the role of secondary screening approaches.
3 Μαρ 2010 · Prostate cancer screening should not occur without an informed decision-making process. Men at average risk should receive this information beginning at age 50 years. Men in higher risk groups should receive this information before age 50 years.
7 Νοε 2020 · Updated prostate cancer guidelines are presented, addressing screening, diagnosis, and local treatment with curative intent. These guidelines rely on the available scientific evidence, and new insights will need to be considered and included on a regular basis.
